Literature DB >> 25757927

Serotonin regulates β-casein expression via 5-HT7 receptors in human mammary epithelial MCF-12A cells.

Takeshi Chiba1, Soichiro Kimura, Katsuo Takahashi, Yasunori Morimoto, Tomoji Maeda, Atsushi Sanbe, Hideo Ueda, Kenzo Kudo.   

Abstract

We previously reported that serotonin (5-hydroxytryptamine; 5-HT) suppresses β-casein expression, a differentiation marker in mammary epithelial cells, via inhibition of the signal transducer and activator of transcription 5 (STAT5) phosphorylation in the human mammary epithelial cell line, MCF-12A. In this study, we investigated the expression pattern of the different 5-HT receptor subtypes in MCF-12A cells, and identified the receptors involved in 5-HT-mediated suppression of β-casein protein expression. β-Casein mRNA expression was inhibited by 30 µM 5-HT in a time-dependent manner. Treatment with 30 µM 5-HT for 72 h decreased β-casein protein levels and STAT5 phosphorylation (pSTAT5). The cells expressed four 5-HT receptors subtypes (5-HTR1D, 2B, 3A, and 7) at the mRNA and protein level, and their expression was elevated by prolactin (PRL) treatment. Additionally, the mRNA levels of 5-HTR1D and 5-HTR7 were significantly higher than the other 5-HT receptors in the cells. Tryptophan hydroxylase 1 mRNA was detectable in the cells in the absence of PRL, and PRL treatment significantly increased its expression. β-Casein and pSTAT5/STAT5 levels in the cells co-treated with 5-HT and a selective 5-HTR1D inhibitor, BRL15572, were equal to those observed in cells treated with 5-HT alone. However, in the cells co-treated with 5-HT and a selective 5-HTR7 inhibitor, SB269970, β-casein and pSTAT5/STAT5 levels increased in a SB269970 concentration-dependent manner. In conclusion, we showed that 5-HT regulates β-casein expression via 5-HTR7 in MCF-12A human mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757927     DOI: 10.1248/bpb.b14-00723

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  1 in total

1.  HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation.

Authors:  Xiaoli Sheng; Wenlin Liu; Zhongming Lu; Mimi Xu; Rui Li; Rong Zhong; Yunxian Li; Tao Liu; Siyi Zhang
Journal:  Ann Transl Med       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.